Christopher Blunden
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 3
-
- Antibiotic Use and Resistance 3
- Co-authors
- Suchitha Bheemreddy (3 shared papers)Kayoko Hayakawa (3 shared papers)Keith S. Kaye (3 shared papers)Jason M. Pogue (3 shared papers)Paul Lephart (3 shared papers)Teena Chopra (3 shared papers)Dror Marchaim (3 shared papers)Robert A. Bonomo (2 shared papers)
- Journals
- The Journal of Pediatrics (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Infection Control and Hospital Epidemiology (1 paper)American Journal of Infection Control (1 paper)American Journal of Medical Quality (1 paper)
- Partner nations
- United StatesIsraelNigeria
In The Last Decade
Christopher Blunden
6 papers receiving 238 citations
Peers
Comparison fields: 5 of 41
- Applied Microbiology and Biotechnology 93
- Molecular Medicine 172
- Clinical Biochemistry 60
- Endocrinology 40
- Pharmacology 74
Countries citing papers authored by Christopher Blunden
This map shows the geographic impact of Christopher Blunden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Blunden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Blunden more than expected).
Fields of papers citing papers by Christopher Blunden
This network shows the impact of papers produced by Christopher Blunden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Blunden. The network helps show where Christopher Blunden may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Blunden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 108 | |
| 2 | 2012 | 64 | |
| 3 | 2012 | 47 | |
| 4 | 2021 | 10 | |
| 5 | 2018 | 9 | |
| 6 | 2020 | 2 | |
| 7 | 2015 | 0 |
About Christopher Blunden
Christopher Blunden is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 7 papers that have together received 240 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Thyroid Disorders and Treatments (1 paper), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Vibrio bacteria research studies (1 paper) and Neonatal Health and Biochemistry (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (93 citations), Molecular Medicine (172 citations), Clinical Biochemistry (60 citations), Endocrinology (40 citations) and Pharmacology (74 citations). Christopher Blunden has collaborated with scholars based in United States, Israel and Nigeria. Frequent co-authors include Suchitha Bheemreddy, Kayoko Hayakawa, Keith S. Kaye, Jason M. Pogue, Paul Lephart, Teena Chopra, Dror Marchaim, Robert A. Bonomo, Federico Pérez and Sorabh Dhar. Their work appears in journals such as The Journal of Pediatrics, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, American Journal of Infection Control and American Journal of Medical Quality.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.